Annual accounts
Small accounts
30/04/2027Filing deadline
Made up to 31/07/2025Due 30/04/2027
- Next accounts made up to
- 31/07/2026
- Last accounts made up to
- 31/07/2025
MYRICX PHARMA LIMITED
Active- 12082645Copy
Copy
Registry details
Reference data exactly as held at Companies House.
Copy registry details
- Registered office
- 2nd Floor, The Westworks Building White City Place, 195 Wood Lane, London W12 7FQ
- Classification (SIC)
- Research and experimental development on biotechnology (72.11 - SIC 2007)
- Accounts type
- Small
Company activity
The 4 most recent documents filed at Companies House.
Pre-Score for UK companies is coming soon
- 15/09/2026View PDF (1 pages)
Current accounting period extended from 2026-07-31 to 2026-12-31
- 11/09/2026View PDF (3 pages)
Particulars of variation of rights attached to shares
- 11/09/2026View PDF (2 pages)
Change of share class name or designation
- 09/09/2026View PDF (8 pages)
Resolutions
Coming soon
What Pre-Score will tell you
- Whether the filed accounts are strengthening or weakening year on year.
- Whether this company files on time, and how often its record changes.
- How its officers and controlling parties connect to other UK companies.
Accounts and confirmation statement
The two filings Companies House requires every year, and where each one stands against its deadline today.
On schedule
Confirmation statement
Confirms the registry record is up to date
- Next statement date
- 02/07/2026
- Last statement dated
- 31/07/2025
Financial performance
The latest figures MYRICX PHARMA LIMITED filed. Okredo holds filed accounts data for 2021–2023; the year-by-year record is on the financials page.
Net Assets
£-3.68M2023
-208.33%vs 20222022: £-1.20M
Total Assets
£1.69M2023
-27.39%vs 20222022: £2.32M
Cash in Bank
£985.11K2023
-35.48%vs 20222022: £1.53M
Total Liabilities
£5.33M2023
54.14%vs 20222022: £3.45M
Employees
82023
+2vs 20222022: 6
Of the 4 measures with an earlier filing to compare against, 1 rose and 3 fell. Net assets moved furthest, down 208.33% on 2022. See the full financial analysis for MYRICX PHARMA LIMITED.
The full financial record
Four ways through MYRICX PHARMA LIMITED's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Cash in Bank · +5.5% a year (CAGR)Three-year trend, 2021–2023Every measure end to end across 2021, 2022 and 2023, with the compound rate behind each one.See what moved5 chartsCharts by indicator5 filed indicators plotted year by year, 2021–2023.Plot the figuresNothing estimatedRatios from the filed figures4 ratios computed from this company's own reported amounts, each shown against the year it was derived from.Check the ratios5 × 3 yearsEvery figure by yearAll 5 measures Okredo tracks across 3 reported years, exactly as filed.Open the table
Employees
Headcount as reported to Companies House for 2021–2023.
| Year | Employees | Change |
|---|---|---|
| 2023 | 8 | +2 |
| 2022 | 6 | +1 |
| 2021 | 5 | – |
Reported employee count increased from 5 in 2021 to 8 in 2023. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
- Company potential
- Risk indicators
- Past performance
- Future prospects
Officers
18Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Corporate Secretary | 11/02/2025–28/08/2026 | 96 | |
| Director | 03/07/2019–10/11/2023 | 8 | |
| Director | 03/07/2019–28/06/2024 | 0 | |
| Director | 28/08/2026–Present | 1 | |
| Director | 19/04/2023–28/08/2026 | 10 | |
| Director | 30/10/2019–28/08/2026 | 16 | |
| Director | 23/02/2021–19/06/2024 | 0 | |
| Director | 28/06/2024–10/11/2025 | 0 | |
| Director | 28/06/2024–28/08/2026 | 0 | |
| Director | 20/09/2024–27/01/2025 | 0 | |
| Director | 28/08/2026–Present | 8 | |
| Secretary | 20/12/2019–30/11/2024 | 0 | |
| Director | 10/11/2023–28/08/2026 | 3 | |
| Director | 03/10/2025–28/08/2026 | 0 | |
| Director | 11/10/2022–10/09/2025 | 0 | |
| Director | 10/11/2025–28/08/2026 | 0 | |
| Director | 30/10/2019–19/04/2023 | 0 | |
| Director | 28/08/2026–Present | 0 |
Persons with significant control
2Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 03/07/2019–30/10/2019 | 0 | |
| 06/08/2020–Present | 0 |
Filing history and recent activity
Every document on the Companies House record, newest first.
- Filings on record
- 75 Since 07/11/2019
- Last 12 months
- 25 +5 vs the year before
- Most recent filing
- 15/09/2026 less than a month ago
What changed in the last year
- Officer changes (14)Latest 08/09/2026
- Registered officeLatest 02/09/2026
- Share capital (4)Latest 02/09/2026
- Accounts filedLatest 04/12/2025
Filing timeline
- 15/09/2026View PDF (1 pages)
Current accounting period extended from 2026-07-31 to 2026-12-31
- 11/09/2026View PDF (3 pages)
Particulars of variation of rights attached to shares
- 11/09/2026View PDF (2 pages)
Change of share class name or designation
- 09/09/2026View PDF (8 pages)
Resolutions
- 09/09/2026View PDF (25 pages)
Memorandum and Articles of Association
- 08/09/2026View PDF (1 pages)
Termination of appointment of Mohit Rawat as a director on 2026-08-28
- 07/09/2026View PDF (1 pages)
Termination of appointment of Michael Karl Bauer as a director on 2026-08-28
- 07/09/2026View PDF (1 pages)
Termination of appointment of Maina Bhaman as a director on 2026-08-28
- 07/09/2026View PDF (1 pages)
Termination of appointment of Jonathan Leslie Tobin as a director on 2026-08-28
- 07/09/2026View PDF (1 pages)
Termination of appointment of Christopher John Martin as a director on 2026-08-28
- 07/09/2026View PDF (1 pages)
Termination of appointment of Jayson Punwani as a director on 2026-08-28
- 02/09/2026View PDF (1 pages)
Termination of appointment of Pennsec Limited as a secretary on 2026-08-28
Showing 12 of 75 filings
See when the next accounts and confirmation statement are due
Similar companies
52 UK companies are similar to MYRICX PHARMA LIMITED, sharing the same company status (Active), the same industry sector and activity group (Research and experimental development on biotechnology) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.
OXFORD ENDOVASCULAR LIMITED
Active9400 Garsington Road, Oxford Business Park, Oxford OX4 2HN
- Activity
- Research and experimental development on biotechnology
- Company no.
- 09769779
- Incorporated
- 09/09/2015
- Employees
- 9
AUXETEC LIMITED
ActiveNexus, Discovery Way, Leeds LS2 3AA
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 12925662
- Incorporated
- 03/10/2020
- Employees
- 9
LASER MICROMACHINING LIMITED
Active12-14 Ffordd Richard Davies, St. Asaph Business Park, St. Asaph, Denbighshire LL17 0LJ
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 05288483
- Incorporated
- 16/11/2004
- Employees
- 9
AGUA VIA LIMITED
ActivePaddock Cottage Sandy Lane, Milford, Godalming GU8 5BL
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 06420717
- Incorporated
- 07/11/2007
- Employees
- 10
ALBRIGHT PRODUCT DESIGN LIMITED
ActiveWilliam Burford House, Lansdown Place Lane, Cheltenham GL50 2LB
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 08597948
- Incorporated
- 04/07/2013
- Employees
- 9
About MYRICX PHARMA LIMITED
A short description of the company, written from its Companies House record.
MYRICX PHARMA LIMITED is a private limited company registered in the United Kingdom, based in 2nd Floor, The Westworks Building White City Place, 195 Wood Lane, London W12 7FQ. Companies House classifies its business as Research and experimental development on biotechnology. It has been on the register for 7 years 2 months.
The register currently records it as active. Its 2023 accounts report net assets of £-3.68M and 8 employees.
MYRICX PHARMA LIMITED: frequently asked questions
Answered from this company's own registry record and filed figures.
What does MYRICX PHARMA LIMITED do?
Companies House records MYRICX PHARMA LIMITED under one registered business activity: Research and experimental development on biotechnology (72.11 - SIC 2007).
Is MYRICX PHARMA LIMITED still active?
MYRICX PHARMA LIMITED is recorded as active on the Companies House register, and has been on it since 03/07/2019.
What are MYRICX PHARMA LIMITED's latest reported financials?
The most recent accounts Okredo holds cover 2023 and report net assets of £-3.68M, total assets of £1.69M, cash in bank of £985.11K and total liabilities of £5.33M.
When did MYRICX PHARMA LIMITED last file with Companies House?
The most recent document on the record is dated 15/09/2026: Current accounting period extended from 2026-07-31 to 2026-12-31, less than a month ago.
When are MYRICX PHARMA LIMITED's next filings due?
On the current registry record, accounts are due by 30/04/2027.
Who runs MYRICX PHARMA LIMITED?
Companies House lists 18 officers (3 currently in post) and 2 people with significant control (1 current).